Two Sigma Investments
CTNM

Two Sigma Investments’s Contineum Therapeutics CTNM Stock Holding History

Two Sigma Investments’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$495K Hold
37,916
– – ﹤0.01% 3751
2025
Q4 		$433K Sell
37,916
-27
-0.1% -$308 ﹤0.01% 3391
2025
Q3 		$446K Sell
37,943
-23,020
-38% -$186K ﹤0.01% 3033
2025
Q2 		$242K Buy
+60,963
New +$265K ﹤0.01% 2859

Other funds holding CTNM

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments's CTNM Position: Q1 2026 in Review

Two Sigma Investments held its Contineum Therapeutics (CTNM) position steady in Q1 2026 at 37,916 shares worth $495K. The position accounts for ﹤0.01% of the portfolio, ranked #3751.

Two Sigma Investments first reported a position in CTNM in Q2 2025 and has held it in 4 quarters since. 90 funds tracked by Wall St. Rank hold CTNM as of Q1 2026.

  • Two Sigma Investments held 37,916 shares of Contineum Therapeutics worth $495K as of Q1 2026.
  • Two Sigma Investments left its Contineum Therapeutics share count unchanged in Q1 2026.
  • Contineum Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3751 holding.
  • Two Sigma Investments first reported a position in Contineum Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 90 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.